Overview
Ani Dong practices practicing medicine in Zhengzhou, China.
Her clinical expertise encompasses Squamous Cell Lung Carcinoma and Renal Cell Carcinoma (RCC).
She is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ani Dong
Is Ani Dong a top-rated expert for Squamous Cell Lung Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Ani Dong is classified as an Experienced expert for Squamous Cell Lung Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ani Dong participate in research or clinical trials?
Yes. Ani Dong has published 9 articles and abstracts on conditions like Squamous Cell Lung Carcinoma. You can view a list of Ani Dong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Renal Cell Carcinoma (RCC)Ms. Dong isExperienced. Learn about Renal Cell Carcinoma (RCC).
- Squamous Cell Lung CarcinomaMs. Dong isExperienced. Learn about Squamous Cell Lung Carcinoma.